Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Progesterone increases alcohol tolerance and withdrawal anxiety, while DHEAS prevents them.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Dock5 is important for skin healing and could help treat diabetic wounds.

RpoS helps Borrelia burgdorferi survive in hosts and adapt to different environments.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

GLP-1 receptor agonists may help or harm hair health, needing more research.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

More research is needed to understand if GLP-1 agonists affect hair health.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

GLP-1 RA medications may be linked to hair loss.